BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24506837)

  • 21. Effects of baicalein on the pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats: possible role of cytochrome P450 3A4 and P-glycoprotein inhibition by baicalein.
    Li C; Kim M; Choi H; Choi J
    Arch Pharm Res; 2011 Nov; 34(11):1965-72. PubMed ID: 22139696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral bioavailability and pharmacokinetics of the new insulin sensitizer DRF-2189 in Wistar rats.
    Jajoo HK; Mamidi RN; Vakkalanka SV; Sathyavageeswaran S; Katneni K; Ayalasomayajula PS; Rao BP; Lohray BB; Subramaniam S
    Arzneimittelforschung; 1999 Feb; 49(2):133-6. PubMed ID: 10083982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of lovastatin on the pharmacokinetics of verapamil and its active metabolite, norverapamil in rats: possible role of P-glycoprotein inhibition by lovastatin.
    Hong SP; Chang KS; Koh YY; Choi DH; Choi JS
    Arch Pharm Res; 2009 Oct; 32(10):1447-52. PubMed ID: 19898809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profound difference in pharmacokinetics between morin and its isomer quercetin in rats.
    Hou YC; Chao PD; Ho HJ; Wen CC; Hsiu SL
    J Pharm Pharmacol; 2003 Feb; 55(2):199-203. PubMed ID: 12631412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of prednisolone on the pharmacokinetics of loratadine after oral and intravenous administration of loratadine in rats.
    Li C; Kim M; Choi JS
    Arch Pharm Res; 2010 Sep; 33(9):1395-400. PubMed ID: 20945138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats.
    Li C; Li X; Choi JS
    Arch Pharm Res; 2009 Jan; 32(1):133-8. PubMed ID: 19183886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of baicalein, an antioxidant, on the bioavailability of doxorubicin in rats: possible role of P-glycoprotein inhibition by baicalein.
    Shin SC; Li C; Choi JS
    Pharmazie; 2009 Sep; 64(9):579-83. PubMed ID: 19827298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats.
    Li X; Choi JS
    Anticancer Res; 2009 Apr; 29(4):1411-5. PubMed ID: 19414395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced oral exposure of diltiazem by the concomitant use of naringin in rats.
    Choi JS; Han HK
    Int J Pharm; 2005 Nov; 305(1-2):122-8. PubMed ID: 16226412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the flavonoid oroxylin A as an inhibitor of P-glycoprotein-mediated cellular efflux.
    Go WJ; Ryu JH; Qiang F; Han HK
    J Nat Prod; 2009 Sep; 72(9):1616-9. PubMed ID: 19739602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of atorvastatin on the intravenous and oral pharmacokinetics of verapamil in rats.
    Choi DH; Chang KS; Hong SP; Choi JS; Han HK
    Biopharm Drug Dispos; 2008 Jan; 29(1):45-50. PubMed ID: 17941000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of piperine, a major component of black pepper, on the intestinal absorption of fexofenadine and its implication on food-drug interaction.
    Jin MJ; Han HK
    J Food Sci; 2010 Apr; 75(3):H93-6. PubMed ID: 20492299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultra-performance liquid chromatography-tandem mass spectrometry method for the determination of febuxostat in dog plasma and its application to a pharmacokinetic study.
    Zhang T; Sun Y; Zhang P; Gao J; Wang S; He Z
    Biomed Chromatogr; 2013 Feb; 27(2):137-41. PubMed ID: 22736298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions between the flavonoid biochanin A and P-glycoprotein substrates in rats: in vitro and in vivo.
    Zhang S; Sagawa K; Arnold RD; Tseng E; Wang X; Morris ME
    J Pharm Sci; 2010 Jan; 99(1):430-41. PubMed ID: 19499569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absorption and enterohepatic circulation of baicalin in rats.
    Xing J; Chen X; Zhong D
    Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of resveratrol on the pharmacokinetics of oral and intravenous nicardipine in rats: possible role of P-glycoprotein inhibition by resveratrol.
    Choi JS; Choi BC; Kang KW
    Pharmazie; 2009 Jan; 64(1):49-52. PubMed ID: 19216231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats.
    Li X; Choi JS
    Int J Pharm; 2007 Jun; 337(1-2):188-93. PubMed ID: 17267149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous quantification of flavonoids in blood plasma by a high-performance liquid chromatography method after oral administration of Blumea balsamifera leaf extracts in rats.
    Nessa F; Ismail Z; Mohamed N; Karupiah S
    Pak J Pharm Sci; 2013 Mar; 26(2):375-81. PubMed ID: 23455210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats.
    Shin SC; Choi JS
    Anticancer Drugs; 2009 Aug; 20(7):584-8. PubMed ID: 19491656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic interactions of concomitant administration of febuxostat and NSAIDs.
    Khosravan R; Wu JT; Joseph-Ridge N; Vernillet L
    J Clin Pharmacol; 2006 Aug; 46(8):855-66. PubMed ID: 16855070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.